Frontiers in Immunology | New and Recent Articles https://www.frontiersin.org/journals/immunology RSS Feed for Frontiers in Immunology | New and Recent Articles en-us Frontiers Feed Generator,version:1 2026-05-13T09:37:13.692+00:00 60 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1808107 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1808107 <![CDATA[Metabolic reprogramming of cholesterol biosynthesis drives macrophage-mediated immune suppression in HPV-negative cervical adenocarcinoma]]> 2026-05-13T00:00:00Z Original Research Jianing ZhangWenjuan WeiYajun ZhangDaqing Wang https://www.frontiersin.org/articles/10.3389/fimmu.2026.1820785 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1820785 <![CDATA[Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities]]> 2026-05-13T00:00:00Z Review Lifei XuBin WangWenwei LiXiandan LuoLixia WangYi Zheng https://www.frontiersin.org/articles/10.3389/fimmu.2026.1846052 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1846052 <![CDATA[Divergent immune cascades activated by metabolic versus mechanical exercise intensity: revisiting cytokine heterogeneity in “moderate-intensity exercise”]]> 2026-05-13T00:00:00Z Perspective Jia-wen WangJian-Jun XunLi-Na Jian https://www.frontiersin.org/articles/10.3389/fimmu.2026.1868391 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1868391 <![CDATA[Editorial: Understanding eQTLs and their Association with Spondyloarthropathies]]> 2026-05-13T00:00:00Z Editorial Matteo Vecellio https://www.frontiersin.org/articles/10.3389/fimmu.2026.1778171 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1778171 <![CDATA[Risk of intestinal involvement in mucocutaneous-onset Behçet’s disease: data from the AIDA network registry]]> 2026-05-13T00:00:00Z Brief Research Report Antonio VitaleValeria CaggianoJessica SbalchieroFrancesco GavioliGiuseppe LopalcoGaafar RagabSilvana GuerrieroIbrahim AlmaglouthAbdurrahman TufanRoberto GiacomelliHaner DireskeneliPiero RuscittiGülen HatemiFrancesco CarubbiEzgi Deniz BatuSeza OzenJurgen SotaHenrique Ayres Mayrink GiardiniMicol FrassiPetros P SfikakisMaria MorroneFederica GattiAmina MaherAyman Abdel-Monem Ahmed MahmoudRosanna DammaccoHamit KucukRiza Can KardasIbrahim Yahya CakirLetizia Pia di CorciaFatma Alibaz ÖnerGizem SevikMartina GentileAlican KarakocAlessia AlunnoHulya Ercan EmreolFrancesca CrisafulliMaria TektonidouFrancesco CicciaMaissa ThabetSerena BugattiAlessandra MilanesiMaria Sole ChimentiBenedetta MonosiMatteo PigaAlberto FlorisAndrea Hinojosa-AzaolaGuillermo Arturo Guaracha-BasañezCecilia Beatrice ChighizolaJosé Hernández-RodríguezMarco CattaliniMarcello GovoniOmbretta ViapianaAdele CivinoDaniela Opris-BelinskiCarla GaggianoRosaria TalaricoAnnarita GiardinaGiacomo EmmiPiercarlo Sarzi PuttiniMaria Cristina MaggioPaola ParronchiPiero PortincasaAlejandra de-la-TorreJuanita Cardona-LópezStefano GentileschiAngela MauroGian Domenico SebastianiMaria Francesca GicchinoAli ŞahinDonato RiganteEmre BilginEmanuela Del GiudiceLuciana BredaAmato De PaulisAlberto Lo GulloŞükran ErtenSamar TharwatLampros FotisMaier ArminAntonella InsalacoAnastasios KaramanakosAlessandro ConfortiÖzgül Soysal GündüzAbdelhfeez MoshrifFrancesca Li GobbiStefania CostiElena BartoloniPatrizia BaroneSerena GuiducciAndrés González-GarcíaInés Hernanz RodriguezGiovanni ContiAnnamaria IagnoccoFatos ÖnenSulaiman M. Al-MayoufAli İbrahim HatemiAlberto BalistreriClaudia FabianiLuca Cantarini https://www.frontiersin.org/articles/10.3389/fimmu.2026.1817221 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1817221 <![CDATA[Serplulimab combined with gemcitabine, nab-paclitaxel, and stereotactic body radiotherapy versus gemcitabine and nab-paclitaxel as first-line treatment for recurrent or metastatic pancreatic ductal adenocarcinoma: a randomized, open-label, multicenter, phase III clinical trial (WGOG-PAN 006/ICSBR-2)]]> 2026-05-13T00:00:00Z Brief Research Report Xin WangPei ZhangDan CaoHuanji Xu https://www.frontiersin.org/articles/10.3389/fimmu.2026.1779393 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1779393 <![CDATA[Complement activation in patients with post-acute sequelae after SARS-CoV-2 infection]]> 2026-05-13T00:00:00Z Brief Research Report Madlene HolmqvistDick J. SjöströmKatherine CarlsonBirgitta GullstrandAnders A. BengtssonRobin KahnTom E. MollnesPer ÅkessonPer H. NilssonFredrik Kahn https://www.frontiersin.org/articles/10.3389/fimmu.2026.1808989 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1808989 <![CDATA[Serum inflammatory cytokines in the progression of depression]]> 2026-05-13T00:00:00Z Mini Review Qing FengZhen YuanQi AnKang WangXiaohui Liu https://www.frontiersin.org/articles/10.3389/fimmu.2026.1826191 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1826191 <![CDATA[Neutrophil extracellular traps in gout: from immune defense to pathological dynamic equilibrium]]> 2026-05-13T00:00:00Z Review Fangfang WangNing TieYong JinHongbin Li https://www.frontiersin.org/articles/10.3389/fimmu.2026.1810955 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1810955 <![CDATA[Generation of functional canine TIL products for solid tumors]]> 2026-05-13T00:00:00Z Original Research Kay M. FoosVeethika PandeyMichael W. JenningsDaniel J. PowellNicola J. Mason https://www.frontiersin.org/articles/10.3389/fimmu.2026.1789297 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1789297 <![CDATA[Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic]]> 2026-05-13T00:00:00Z Review Huiying LiuXunjun LiJiang YuTao Chen https://www.frontiersin.org/articles/10.3389/fimmu.2026.1795363 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1795363 <![CDATA[Hyperthermia enhances the efficacy of PD-1 inhibitor plus chemotherapy in PD-L1 CPS-negative advanced gastric cancer]]> 2026-05-13T00:00:00Z Original Research Weihang LiXin SunPing LiTing WangPanling Xu https://www.frontiersin.org/articles/10.3389/fimmu.2026.1801628 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1801628 <![CDATA[The role of the complement system in gastrointestinal-related diseases]]> 2026-05-13T00:00:00Z Review Bo YongZixiang LuoBo LuoJinbo LiuZhangrui ZengXiaoli Zheng https://www.frontiersin.org/articles/10.3389/fimmu.2026.1827181 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1827181 <![CDATA[Convergent death programs in chronic obstructive pulmonary disease: how pyroptotic and ferroptotic crosstalk reshapes therapeutic paradigms]]> 2026-05-13T00:00:00Z Review Aisi HuangShiming LiuJiao Lan https://www.frontiersin.org/articles/10.3389/fimmu.2026.1748748 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1748748 <![CDATA[The inhibition of the Aβ-ASC interaction site suppresses β-amyloid aggregation and cytotoxicity]]> 2026-05-13T00:00:00Z Original Research Lan ZhaoXue XiaSiqi WangRui LiuZhenjiang LiuDong SunXianghui YuHui Wu https://www.frontiersin.org/articles/10.3389/fimmu.2026.1792996 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1792996 <![CDATA[miRNA profiling shows shared signatures in pediatric asthma, obesity and their comorbidity]]> 2026-05-13T00:00:00Z Original Research Harshita ShaileshMohamed Nadhir DjekidelSafa NoorLena HayatiStefan WorgallSouhaila Al KhodorIbrahim Janahi https://www.frontiersin.org/articles/10.3389/fimmu.2026.1837640 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1837640 <![CDATA[Sex-specific reporting patterns and onset timing of immune-related adverse events associated with nivolumab and pembrolizumab: a dual-database pharmacovigilance analysis]]> 2026-05-13T00:00:00Z Original Research Yu BaiHong LiuHao Meng https://www.frontiersin.org/articles/10.3389/fimmu.2026.1824573 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1824573 <![CDATA[Beyond the usual suspects: rethinking post-stroke immunosuppression]]> 2026-05-13T00:00:00Z Review Laia Ascaso-VidalAlba SimatsDavid Brea https://www.frontiersin.org/articles/10.3389/fimmu.2026.1747043 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1747043 <![CDATA[Lactylation-mediated remodelling of the breast cancer microenvironment: single-cell multidimensional analysis and prognostic model construction]]> 2026-05-13T00:00:00Z Original Research Jiaxin ChenYixue HaoYinghua FengYongjing DaiHaoyuan ShiLi Zhu https://www.frontiersin.org/articles/10.3389/fimmu.2026.1834635 https://www.frontiersin.org/articles/10.3389/fimmu.2026.1834635 <![CDATA[Clinical characteristics and long-term prognosis of talaromycosis in children with novel and reported inborn errors of immunity]]> 2026-05-13T00:00:00Z Original Research Qian LuXianghui LiZhiwen JiangTiantian LiBingkun LiLan HuangQihua HuangDongmei HuChunying LvGuoqun LiuJialing ZhongJingjing LinLiuwei LiaoQianfeng QinSha QinHaotian ShaoZhiyi WangXiuying LiLi JiangXinyu ZhangLili WeiJiarong LiangDongyan ZhengShuangjie WangWeixuan WuKaisu PanYanqing ZhengYanning LiQing TangMin JiangWanqing LiaoCunwei Cao